Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.

Dianbo LiuKaren L OlsonShannon F ManziKenneth D Mandl

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2021)

The number of people who might benefit from pharmacogenomic-guided prescribing is substantial. Future work should address obstacles to integrating genomic data into prescriber workflows, complex factors contributing to the magnitude of benefit, and the clinical availability of reliable on-demand or pre-emptive pharmacogenomic testing.

Keyphrases

end stage renal disease
ejection fraction
primary care
newly diagnosed
chronic kidney disease
peritoneal dialysis
electronic health record
gene expression
big data
machine learning
data analysis
drug induced